Clinical trials
Phase 1 Testicular Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 4 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Terminated | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 8 |
| National Institutes of Health Clinical Center (CC) | 4 |
| City of Hope Medical Center | 2 |
| Jonsson Comprehensive Cancer Center | 2 |
| Regeneron Pharmaceuticals | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Alaunos Therapeutics | 1 |
| Alliance for Clinical Trials in Oncology | 1 |
| Brian Henick, MD | 1 |
| Case Comprehensive Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Testicular Neoplasms | 39 |
| Breast Neoplasms | 20 |
| Neoplasms | 15 |
| Ovarian Neoplasms | 15 |
| Carcinoma, Ovarian Epithelial | 14 |
| Sarcoma | 14 |
| Carcinoma, Hepatocellular | 13 |
| Endometrial Neoplasms | 13 |
| Neuroblastoma | 13 |
| Stomach Neoplasms | 12 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.